Related Experiment Video
Updated: Mar 3, 2026
Investigating Intestinal Inflammation in DSS-induced Model of IBD
Published on: February 1, 2012
Measuring inflammation in IBD with an OSM-ostat
1Department of Dermatology, University of California, San Francisco, San Francisco, CA 94143, USA.
Oncostatin M is elevated in inflammatory bowel disease, potentially driving inflammation and predicting poor response to anti-tumor necrosis factor therapies.
Area of Science:
- Gastroenterology and Immunology
Background:
- Inflammatory bowel disease (IBD) involves chronic intestinal inflammation.
- Oncostatin M (OSM) is a cytokine implicated in inflammatory conditions.
Purpose of the Study:
- To investigate the role of Oncostatin M in inflammatory bowel disease.
- To determine if Oncostatin M levels predict treatment response to anti-TNF therapy.
Main Methods:
- Analysis of Oncostatin M levels in IBD patients.
- Correlation of Oncostatin M levels with disease activity and treatment outcomes.
Main Results:
- Oncostatin M was found to be elevated in patients with inflammatory bowel disease.
- Higher Oncostatin M levels were associated with intestinal stroma cell inflammation.
- Elevated Oncostatin M predicted nonresponsiveness to anti-tumor necrosis factor (anti-TNF) therapy.
Conclusions:
- Oncostatin M may contribute to intestinal inflammation in IBD.
- Oncostatin M serves as a potential biomarker for predicting anti-TNF therapy unresponsiveness in IBD.
More Related Videos
09:11Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
Published on: February 14, 2021
15:49Flexible Colonoscopy in Mice to Evaluate the Severity of Colitis and Colorectal Tumors Using a Validated Endoscopic Scoring System
Published on: October 16, 2013
Related Concept Videos
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...